Literature DB >> 9818675

Postradiation morphea.

M H Gollob1, J G Dekoven, M J Bell, D Assaad, J Rao.   

Abstract

We describe a 54-year-old woman who developed right breast morphea after radiotherapy following a lumpectomy for infiltrating lobular carcinoma. Skin biopsy confirmed the histological features of morphea. Treatment was initiated with both topical and intralesional steroid, resulting in marked improvement. Morphea following radiotherapy is an infrequently recognized phenomenon. However, when diagnosed early it may be effectively managed with local steroid treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818675

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Post-Irradiation Morphea: Case report and review of the literature.

Authors:  Ammar Alhathlool; Rüdiger Hein; Christian Andres; Johannes Ring; Bernadette Eberlein
Journal:  J Dermatol Case Rep       Date:  2012-09-28

2.  Localized morphea--a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea.

Authors:  Thomas Herrmann; Claudia Günther; Peter Csere
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

3.  Diffuse fasciitis with eosinophilia developing after local irradiation for breast cancer.

Authors:  Noëlle S Sherber; Fredrick M Wigley; Stephen A Paget
Journal:  Clin Rheumatol       Date:  2009-02-18       Impact factor: 2.980

4.  Post-Irradiation Morphea of the Breast in a Patient with Subacute Cutaneous Lupus Erythematosus: Case Report and a Literature Review.

Authors:  Carole Anouk Zahn; Laurence Feldmeyer; Roland Blum; Carlo Mainetti
Journal:  Case Rep Dermatol       Date:  2022-05-30

5.  Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.

Authors:  Richard Partl; Peter Regitnig; Gerlinde Tauber; Michaela Pötscher; Vesna Bjelic-Radisic; Karin S Kapp
Journal:  Strahlenther Onkol       Date:  2018-07-16       Impact factor: 3.621

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.